Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ISG20L2 pseudogene 2 (ISG20L2P2) is a processed pseudogene in the human genome, derived from the ISG20L2 gene (Interferon Stimulated Exonuclease Gene 20 Like 2)[5][3]. It does not code for a protein and therefore does not have the biochemical activity or biological function of its parent gene. Pseudogenes are typically considered non-functional and are not included among molecular targets in drug discovery or biomedical research. The parent gene, ISG20L2, encodes a 3'-5' exoribonuclease involved in rRNA processing, but ISG20L2P2 does not contribute directly to this activity[1][5].\n\nKey insight: For structured information and molecular target databases, a pseudogene such as ISG20L2P2 should not be included as a functional therapeutic target. If you are seeking data on a pharmacologically relevant molecule, refer to the functional gene ISG20L2, not its pseudogene variants[1][5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ISG20L2 pseudogene 2 (ISG20L2P2).